Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
cf102 adenosine a3 receptor NA Clinical trial target TTD , DGIDB Hepatitis C[MeSHID:D006526]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Liver carcinoma[MeSHID:D006528]
NA phase 2 unknown
cf102 adenosine a3 receptor NA Clinical trial target TTD , DGIDB Hepatitis C[MeSHID:D006526]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Liver carcinoma[MeSHID:D006528]
1.91 phase 2 agonist
cf102 adenosine a3 receptor NA Clinical trial target TTD , DGIDB Hepatitis C[MeSHID:D006526]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Liver carcinoma[MeSHID:D006528]
1.91 phase 2 unknown
click here to return to the previous page